EUVIMEDAvasta EUVIMED
Open access · CC BY 4.0

Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy

Georgios Daouacher iD, Jessica Carlsson, Pernilla Sundqvist, Mauritz Waldén

BJUI Compass · 2026-03 · 7 (3)

DOI: 10.1002/bco2.70193 ↗

At a glance

Journal article in BJUI Compass, published online on 2026-03-22. Written by Georgios Daouacher and 3 co-authors. Institution: Faculty of Medicine and Health Örebro University Örebro Sweden. 29 references. The full text is freely available (open access, CC BY 4.0). Funded by: Region Värmland.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Objectives

To compare oncological outcomes after extended pelvic lymph node dissection (PLND) versus limited in patients with high‐risk prostate cancer (PCa) undergoing curative external beam radiation therapy (EBRT). Patients and Methods From 3627 men with PCa at a single centre between 2000 and 2013, 167 with high‐risk, age ≤75, Gleason score 6–10, clinical stage T1–T3, PSA < 100 ng/ml, no distant metastases (M1) and node‐negative at the obturator fossa, underwent PLND before curative EBRT. Of these, 90 received limited, and 77 underwent extended PLND. Mean follow‐up (SD) was 14.9 yr (5.8) for the limited and 12.3 yr (3.3) for the extended PLND. Primary endpoint was biochemical recurrence (BCR), secondary M1, cancer–specific mortality (CSM), overall mortality (OM). HR, KM and Cox regression models adjusted for age and Cambridge prognostic group (CPG) score. RR, RD at 11 yr.

Results

Extended PLND was associated with a significantly lower risk for BCR (HR: 0.51, 95% CI: 0.31–0.86, p = 0.01) (RR: 0.43, 95% CI: 0.26–0.69, p = 0.001 ), lower risk of M1 (HR: 0.22, 95% CI: 0.08–02.65, p = 0.006 ) (RR: 0.26, 95% CI: 0.09–0.73, p = 0.004 ) and lower CSM compared with limited PLND (HR: 0.31, 95% CI: 0.08–0.65 p = 0.035) (RR 0.27, 95% CI: 0.08–0.91, p = 0.028). OM did not differ significantly.

Conclusions

Extended PLND prior to curative ERBT shows reductions in BCR, M1 and CSM long‐term outcomes following extended versus limited PLND. Extended PLND can be considered in cases with high‐risk PCa prior to curative EBRT.

Subjects

Author keywords

external beam radiation therapyhigh‐risk prostate cancerpelvic lymph node dissectionprostate cancer: biochemical recurrence

Authors and institutions

  • Faculty of Medicine and Health Örebro University Örebro Sweden.
  • Department of Urology Central Hospital of Karlstad Karlstad Sweden.
  • Department of Urology, Faculty of Medicine and Health Örebro University Örebro Sweden.

ORCID profiles: Georgios Daouacher

Funding

  • Region Värmland

Cite

APA

Daouacher, G., Carlsson, J., Sundqvist, P., & Waldén, M. (2026). Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy. BJUI Compass, 7(3). https://doi.org/10.1002/bco2.70193

Vancouver

Daouacher G, Carlsson J, Sundqvist P, Waldén M. Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy. BJUI Compass. 2026;7(3). doi:10.1002/bco2.70193

BibTeX
@article{Daouacher2026,
  author = {Daouacher, Georgios and Carlsson, Jessica and Sundqvist, Pernilla and Waldén, Mauritz},
  title = {Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy},
  journal = {BJUI Compass},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.1002/bco2.70193}
}
Start for free →